Awareness of gestational diabetes mellitus foetal-maternal risks: an Italian cohort study on pregnant women

Autor: Paola Quaresima, Federica Visconti, Fabiana Interlandi, Luigi Puccio, Patrizia Caroleo, Giuseppina Amendola, Michele Morelli, Roberta Venturella, Costantino Di Carlo

Publikováno v: BMC Pregnancy and Childbirth, Vol 21, Iss 1, Pp 1-8 (2021)

Abstract Background Gestational diabetes mellitus (GDM) incidence is increasing worldwide. It represents a major risk factor for adverse foetal-maternal outcomes. Awareness among women in regard to GDM-related risks (in particular foetus ones) has be

Externí odkaz: https://doaj.org/article/dace1f10b43749da95d94a48a5d15ebf

Long-Term Effectiveness and Safety of SGLT-2 Inhibitors in an Italian Cohort of Patients with Type 2 Diabetes Mellitus

Autor: Maria Mirabelli, Eusebio Chiefari, Patrizia Caroleo, Raffaella Vero, Francesco Saverio Brunetti, Domenica Maria Corigliano, Biagio Arcidiacono, Daniela Patrizia Foti, Luigi Puccio, Antonio Brunetti

Publikováno v: Journal of Diabetes Research, Vol 2019 (2019)

Background. SGLT-2 (sodium-glucose cotransporter-2) inhibitors are a novel class of oral hypoglycemic agents for the management of type 2 diabetes mellitus (T2DM). Herein, we aimed to assess the long-term effectiveness and safety of SGLT-2 inhibitors

Externí odkaz: https://doaj.org/article/faca723858df47a291516a9102faefea

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes

Autor: Daniela Foti, Vera Tocci, Emanuela Greco, Eusebio Chiefari, Stefania Giuliano, Luigi Puccio, Antonio Aversa, Antonio Brunetti, Maria Mirabelli, Raúl M. Luque, Patrizia Caroleo

Publikováno v: Journal of Clinical Medicine 10(5), 985 (2021)
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Journal of Clinical Medicine
Volume 10
Issue 5
Helvia: Repositorio Institucional de la Universidad de Córdoba
Universidad de Córdoba
Journal of Clinical Medicine, Vol 10, Iss 985, p 985 (2021)

Aims and methods: The aim of this monocentric retrospective observational study was to evaluate the 18-month safety and effectiveness of GLP-1 receptor agonist (GLP-1 RA) dulaglutide (DU) 1.5 mg/once weekly as an add-on to metformin (MET) or MET plus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ece648a551863b3f91599f0d37ccc01
http://hdl.handle.net/10396/21105

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes

Autor: Antonio Brunetti, Daniela Foti, Luigi Puccio, Stefania Giuliano, Eusebio Chiefari, Francesco Saverio Brunetti, Biagio Arcidiacono, Maria Mirabelli, Patrizia Caroleo, Sinan Tanyolaç, Domenica Maria Corigliano

Publikováno v: International Journal of Environmental Research and Public Health, Vol 17, Iss 1, p 207 (2019)
International Journal of Environmental Research and Public Health
Volume 17
Issue 1

Background: Liraglutide is the first glucagon-like peptide-1 receptor agonist (GLP-1 RA) based on the human GLP-1 sequence, with potential weight loss benefits, approved for the treatment of type 2 diabetes (T2D) mellitus. Herein, we aimed to assess

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c088fc6eec5e721e09b294ce2656f7
https://doi.org/10.3390/ijerph17010207

Awareness of gestational diabetes mellitus foetal-maternal risks: an Italian cohort study on pregnant women.

Autor: Quaresima, Paola¹ dr.paolaquaresima@gmail.com, Visconti, Federica¹, Interlandi, Fabiana¹, Puccio, Luigi², Caroleo, Patrizia², Amendola, Giuseppina¹, Morelli, Michele³, Venturella, Roberta¹, Di Carlo, Costantino¹

Publikováno v: BMC Pregnancy & Childbirth. 10/9/2021, Vol. 21 Issue 1, p1-8. 8p.